Oncology Voice Network
Join to access to all OVN content. Join for Free

Insights

Insights you can use from the thought leaders behind Oncology Voice Network, delivered to you every week.

Insight #5
Data Generation Is Not the Problem. Data Translation Is.

Data Generation Is Not the Problem. Data Translation Is.

The industry generates more data than ever. The problem is that most of it never reaches the people making the decisions that matter.

...

Jun 22nd • min read
Insight #6
Approval Without Access Is Failure.

Approval Without Access Is Failure.

A drug can win regulatory approval and still never reach the patients who need it. Approval is not the finish line — access is.

...

Jun 22nd • min read
Insight #4
The Industry Cuts Programs Too Early. And Learns Too Little.

The Industry Cuts Programs Too Early. And Learns Too Little.

The industry calls it a recruitment problem.

• Why "patient centricity" without patient inclusion is a label, not a strategy

• What the design decisions driving dropout actually look like

• The one...

Jun 15th • 5 mins read
Insight #3
Patient Centricity Is a Myth Without Patient Inclusion.

Patient Centricity Is a Myth Without Patient Inclusion.

A patient with stage-four lung cancer drives three hours to a clinical trial site.

The visit is for a five-minute blood draw.

He drops out the same day.

 

It was logged as a...

Jun 8th • min read
Insight #2
Clinical Trial Design Fails in the Details. Not Science.

Clinical Trial Design Fails in the Details. Not Science.

Clinical trial design fails in the details, not the science.

We invest billions in developing breakthrough oncology therapies, then exclude real patients because of outdated templates and operational inertia.

Jun 1st • min read
Insight #1
Silos Aren’t a Structural Problem. They’re an Incentive Problem.

Silos Aren’t a Structural Problem. They’re an Incentive Problem.

A team celebrates a successful $30 million manufacturing validation campaign.

 

 

...

May 18th • min read